MedTrace Logo

Air Optix Night and Day Aqua (AONDA) Retrospective Study 1

NCT05790928 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2023-05-25

No results posted yet for this study

Summary

The purpose of this study is to assess long term performance and safety of AONDA in a real world setting when worn as daily wear or continuous wear for vision correction. This study will be used to support AONDA's marketability in Europe and other locations.

Conditions

  • Refractive Ametropia
  • Hyperopia
  • Myopia

Interventions

DEVICE

Lotrafilcon A spherical contact lenses

CE-marked silicone hydrogel contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia) in persons with minimal astigmatism that does not interfere with visual acuity

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, CRD · Alcon Research, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-25
Primary Completion
2023-03-31
Completion
2023-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05790928 on ClinicalTrials.gov